Alterations of platelet biochemical and functional properties in newly diagnosed type 1 diabetes: A role in cardiovascular risk?

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 3, 2011, Pages 277-285

  Vignini, Arianna ^a   Moroni, Cinzia ^a   Nanetti, Laura ^a   Raffaelli, Francesca ^a   Cester, Annamaria ^a   Gabrielli, Orazio ^a   Cherubini, Valentino ^a   Mazzanti, Laura ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Nitric oxide; Oxidative stress; Pediatric diabetes; Peroxynitrite; Platelets

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); HEMOGLOBIN A1C; NITRIC OXIDE; PEROXYNITRITE;

ADOLESCENT; ANISOTROPY; ARTICLE; CARDIOVASCULAR RISK; CELL MEMBRANE FLUIDITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE FUNCTION AND CHARACTERISTICS; WESTERN BLOTTING;

ADOLESCENT; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIPHENYLHEXATRIENE; FEMALE; FLUORESCENCE POLARIZATION; HUMANS; INFANT; MALE; MEMBRANE FLUIDITY; NITRIC OXIDE; PEROXYNITROUS ACID; RISK; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 79952167223     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1173     Document Type: Article

References (36)

1. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16: 466-471.
2. Komulainen J, Kulmala P, Savola K, et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DIME) Study Group. Diabetes Care 1999; 22: 1950-1955.
3. Libby P, Nathan DM, Abraham K, et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on cardiovascular complications of type 1 diabetes mellitus. Circulation 2005; 111: 3489-3493.
4. Krishnan S, Short KR. Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes. J Cardiometab Syndr 2009; 4: 50-56.
5. Gillespie KM, Gale EAM, Pingley PJ. High familial risk and genetic susceptibility in early onset childhood. Diabetes 2002; 51: 210-214.
6. Joshua IG, Zhang Q, Falcone JC, Bratcher AP, Rodriguez WE, Tyagi SC. Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide. J Cell Biochem 2005; 96: 1149-1156.
7. Ceriello A. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. Diabetes Nutr Metab 1999; 12: 42-46.
8. Mazzanti L, Mutus B. Diabetes-induced alterations in platelet metabolism. Clin Biochem 1997; 30: 509-515.
9. Mazzanti L, Rabini RA, Fumelli P, et al. Altered platelet membrane dynamic properties in type 1 diabetes. Diabetes 1997; 46: 2069-2074.
10. Waczulíkova I, Sikurova L, Carsky J. Fluidity gradient of erythrocyte membranes in diabetics: the effect of resorcylidene aminoguanidine. Bioelectrochemistry 2002; 55: 53-55.
11. Jorgensen PL, Hakansson KO, Karlish SJD. Structure and mechanism of Na, K-ATPase: functional sites and their interactions. Annu Rev Physiol 2003; 65: 817-849.
12. Rabini RA, Staffolani R, Fumelli P, Mutus B, Curatola G, Mazzanti L. Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients. Diabetologia 1998; 41: 101-104.
13. Abakumov MM, Golikov PP. Nitric oxide and blood coagulation system in clinical practice. Vestn Ross Akad Med Nauk 2005; 10: 53-56.
14. Tannous M, Rabini RA, Vignini A, et al. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 1999; 42: 539-544.
15. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
16. Bridges AB, Fisher TC, Scot N, McLaren M, Belch JJF. Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers. Free Radic Res 1992; 16: 89-97.
17. Akai T. On the measurement of glycosylated hemoglobin. In Vensonic Seminar, Proceedings 1 Tokyo, Baba S, Okuda K (eds). Kyoto Daiichi Kagaku Co: Kobe, 1982; 1117-1125.
18. Rao GHR. Measurement of ionized calcium in normal human blood platelets. Anal Biochem 1988; 169: 400-404.
19. ++ transport system. J Biochem 1989; 263: 547-552.
20. Fiorini R, Curatola G. Membrane heterogeneity studied by fluorescence lifetime distributions of DPH and TMA-DPH. Appl Fluorescence Technol 1991; 3: 33-38.
21. Sheridan NP, Block ER. Plasma membranes fluidity measurements in intact endothelial cells: effect of hyperoxia on fluorescence anisotropies of 1-(4-(trimethylamino)phenyl)-6-phenylhexa-1, 3, 5-triene. J Cell Physiol 1988; 134: 117-123.
22. Kitao T, Hattori K. Inhibition of erythrocytes ATPase activity by aclacinomycin and reverse effect of ascorbate on ATPase activity. Experientia 1983; 39: 1362-1364.
23. Fiske CH, Subarrow Y. The colorimetric determination of phosphorus. J Bio Chem 1925; 66: 375-400.
24. Bradford M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
25. Archer S. Measurement of nitric oxide in biological models. FASEB J 1993; 7: 349-360.
26. Kostolanská J, Jakus V, Barák L. Glycation and lipid peroxidation in children and adolescents with type 1 diabetes mellitus with and without diabetic complications. J Pediatr Endocrinol Metab 2009; 22: 635-643.
27. +ATPase activity in rabbit aorta by hyperglycemia. J Clin Invest 1992; 90: 727-732.
28. Tomasian D, Keaney JF Jr, Vita JA. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc Res 2000; 47: 426-435.
29. Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 1991; 87: 1643-1648.
30. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-1701.
31. Bojunga J, Dresar B, Kusterer K, Sterner-Kock A, Konrad T, Usadel KH. Tissue-specific expression of endothelial and inducible nitric oxide synthase and oxidative stress in streptozotocin-induced diabetic rats. Diabetes 2001; 50: 148.
32. Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007; 75: 291-302.
33. + ATPase activity. Nitric Oxide 2000; 4: 333-342.
34. 2+-ATPase activities involved in sperm motility through peroxynitrite formation? Reprod Biomed Online 2009; 18: 132-140.
35. Kasina S, Wasia R, Fasim A, Radhika KV, Singh SS. Phorbol ester mediated activation of inducible nitric oxide synthase results in platelet profilin nitration. Nitric Oxide 2006; 14: 65-71.
36. Martin-Gallan P, Carrascosa A, Gussinye M, Domingues C. Estimation of lipoperoxidative damage and antioxidant status in diabetic children: relationship with individual antioxidants. Free Radic Res 2005; 39: 933-942.